@dansfera: This breakdown of a **$30 million trial disaster** is crucial viewing. The core issue? Communication breakdowns—happening a staggering eight times out of ten! Discover how overlooking essential steps, like getting the review team aligned *before* launch or failing to secure a Special Protocol Assessment (SPA) with the FDA, turns massive investments into cautionary tales. It’s a masterclass in the high cost of not asking the right questions upfront. #ClinicalTrials #FDA #DrugDevelopment #BusinessFail #MedicalTech